Pleural mesothelioma cell-derived sEVs promote epithelial-to-mesenchymal transition and T-cell suppression through the PD-L1 pathway

Cancer is not a single, static enemy; it is a shifting landscape where cells constantly change their behavior to survive. In the case of pleural mesothelioma, a deadly cancer of the lung lining often caused by asbestos exposure, the disease is particularly difficult to treat because it can hide from the body's immune system. The immune system normally patrols the body, identifying and destroying abnormal cells, but cancer cells have learned to wear disguises. One of the most effective disguises involves a protein called PD-L1. When a cancer cell displays this protein on its surface, it acts like a "do not disturb" sign for the immune system's T-cells, the soldiers that hunt down infections and tumors. If the T-cells see this sign, they stop attacking, allowing the cancer to grow unchecked.

Another key factor in how cancer spreads is a process called epithelial-to-mesenchymal transition, or EMT. In a healthy body, cells are often organized in tight, stationary groups, like bricks in a wall. When a cell undergoes EMT, it loses its grip on its neighbors and transforms into a more mobile, invasive shape, similar to a traveler packing a bag to leave home. This change allows the cancer to break away from the original tumor and spread to other parts of the body. Researchers have long suspected that these two processes—the ability to hide from the immune system and the ability to become mobile—are linked, but the exact mechanism by which one cancer cell teaches these dangerous traits to its neighbors has remained unclear.

A team of scientists at the University of Technology Sydney and other institutions has now uncovered a direct line of communication that explains this link. They discovered that the most aggressive forms of mesothelioma cells do not just change on their own; they actively reprogram their neighbors by sending out tiny, microscopic packages. These packages, known as small extracellular vesicles, are like sealed envelopes released by cells into the surrounding fluid. The researchers found that the aggressive, mobile cancer cells fill these vesicles with specific instructions, including the PD-L1 protein and other signals that trigger the EMT process. When these vesicles are absorbed by the more stationary, less aggressive cancer cells, they force those cells to change their shape and put up their own "do not disturb" signs, effectively turning a quiet tumor into a chaotic, immune-evasive one.

To understand how this happens, the researchers first looked at the different types of mesothelioma cells. They identified two main groups: one that looks like a tight cluster of round cells (epithelial) and another that looks like stretched, fibrous strands (biphasic or mesenchymal). The stretched cells were naturally more dangerous; they moved faster, grew more aggressively, and displayed high levels of the PD-L1 protein. The round cells, by contrast, were more stationary and had low levels of PD-L1. The team then isolated the tiny vesicles released by the dangerous, stretched cells and introduced them to the harmless, round cells in a laboratory dish.

The result was immediate and dramatic. Within days, the round cells began to change. They lost their tight, circular shape and stretched out, adopting the mobile, fibrous appearance of the dangerous cells. At the same time, they began to produce the PD-L1 protein, which they had not made before. The researchers confirmed that this transformation was driven specifically by the contents of the vesicles, not by the fluid surrounding the cells. When they removed the vesicles from the fluid, the round cells remained unchanged. This proved that the vesicles themselves were the delivery system for the aggressive traits.

The study went further to see how this communication affected the immune system. The researchers created a three-dimensional model of a tumor, embedding the cancer cells in a gel that mimics the human body and adding immune cells to the mix. When they introduced the vesicles from the aggressive cells into this model, the immune system's T-cells were suppressed. The T-cells, which should have been attacking the tumor, stopped dividing and became less active. The cancer cells, having received the vesicles, had upregulated their PD-L1 levels, successfully tricking the immune system into standing down. This happened in both human and mouse cell models, suggesting the mechanism is a fundamental part of how this disease progresses.

The scientists also analyzed the contents of these vesicles using advanced protein mapping. They found that the vesicles from the aggressive cells were packed with specific proteins related to cell movement and stress response, while the vesicles from the stationary cells contained different proteins associated with a stable, organized state. This difference in cargo explains why the vesicles have such a powerful effect; they are not just empty bubbles but are loaded with the specific tools needed to rewire a cell's behavior. The researchers also noted that the aggressive cells released a molecule called TGF-beta, which helped trigger the changes in the receiving cells, further reinforcing the link between the vesicles and the transformation.

This discovery changes the way scientists view the progression of mesothelioma. It suggests that the tumor does not just consist of a few bad cells that happen to be aggressive; rather, the aggressive cells actively recruit the rest of the tumor to join them in their escape from the immune system. By sending out these vesicles, the dangerous cells create a hostile environment where the immune system cannot function, and where all the cells become more mobile and invasive. The study highlights that blocking this communication channel—preventing the vesicles from delivering their message—could be a new way to treat the disease. If the immune system is no longer suppressed by these vesicles, it might be able to recognize and destroy the tumor cells more effectively, even in cases where the cancer has become resistant to current therapies.

The findings provide a clear picture of how a tumor evolves from a collection of cells into a coordinated, immune-evasive organism. The aggressive cells act as the architects, sending out the blueprints for survival and mobility to the rest of the population. For patients with mesothelioma, who currently face very limited treatment options, understanding this mechanism offers a new target for future therapies. Instead of just trying to kill the cancer cells, doctors might one day be able to interrupt the signals they send to each other, keeping the tumor in a state where the immune system can still fight it. The research confirms that the battle against cancer is not just about the strength of the immune system, but also about the ability of the tumor to silence it, and that stopping that silence may be the key to winning the fight.